Skip to main content

Table 1 Patient demographics

From: Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)

Characteristic

Number of patients (%), N = 18

Gender

Male

12

(67)

Female

6

(33)

Age (years)

  

Median

60

 

Range

49 -74

 

ECOG performance

Grade 0

16

(89)

Grade 1

2

(11)

Body mass index (kg/m2)

Median

21

 

Range

20 - 24

 

Primary site

  

Cavity of the mouth

8

(44)

Oropharynx

10

(56)

Tumor volume (ml) of primary tumor

Median

25

 

Range

3 - 84

 

AJCC stage

III

2

(11)

IVA

16

(89)

HPV status

  

Negative

15

(83)

Positive

3

(17)

  1. ECOG, Eastern Cooperative Oncology Group; AJCC, American Joint Committee on Cancer; HPV, Human papilloma virus.